2023
Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring
Ginder C, Li J, Halperin J, Akar J, Martin D, Chattopadhyay I, Upadhyay G. Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. Journal Of The American College Of Cardiology 2023, 81: 949-961. PMID: 36889873, DOI: 10.1016/j.jacc.2022.12.024.Peer-Reviewed Original ResearchConceptsAppropriate device therapyMalignant ventricular arrhythmiasDevice therapyVentricular arrhythmiasImplantable cardioverter-defibrillator therapyLogistic regressionSeparate multivariable logistic regressionsLead impedanceAppropriate ICD therapyCardioverter-defibrillator therapyCardiac resynchronization therapyMultivariable logistic regressionRemote monitoring dataShock lead impedanceAtrial lead impedanceICD therapyHeart failureResynchronization therapyAppropriate therapyAtrial tachyarrhythmiasVentricular tachycardiaVentricular fibrillationDefibrillator devicesHeart ratePatients
2019
Body mass index and outcomes of cardiac resynchronization with implantable cardioverter‐defibrillator therapy in older patients with heart failure
Echouffo‐Tcheugui J, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter‐defibrillator therapy in older patients with heart failure. European Journal Of Heart Failure 2019, 21: 1093-1102. PMID: 31359595, DOI: 10.1002/ejhf.1552.Peer-Reviewed Original ResearchConceptsBody mass indexDevice-related complicationsNormal weightMass indexNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryImplantable Cardioverter-Defibrillator RegistryImplantable cardioverter-defibrillator therapyClass III obesityHeart failure outcomesCardioverter-defibrillator therapyObesity class IObesity class IICardiac resynchronization therapyObesity class IIIHF patientsUnderweight patientsDefibrillator implantationElderly patientsHazard ratioObese patientsOlder patientsBMI categoriesHeart failureResynchronization therapyCardiac resynchronizationWearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis
Masri A, Altibi A, Erqou S, Zmaili M, Saleh A, Al-Adham R, Ayoub K, Baghal M, Alkukhun L, Barakat A, Jain S, Saba S, Adelstein E. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis. JACC Clinical Electrophysiology 2019, 5: 152-161. PMID: 30784684, PMCID: PMC6383782, DOI: 10.1016/j.jacep.2018.11.011.Peer-Reviewed Original ResearchConceptsRandomized Controlled TrialsWearable cardioverter-defibrillator therapyWearable cardioverter-defibrillatorVEST trialSudden cardiac deathDerSimonian and Laird methodCardiac deathMonths of follow-upPrevention of sudden cardiac deathA Systematic ReviewPrimary preventionOutcomes of patientsCardioverter-defibrillator therapyLaird methodObservational studyMeta-analysisGoogle ScholarIschemic cardiomyopathyMedical therapyFollow-upCardioverter-defibrillatorPreventionTherapyVestPersons
2018
P1025Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a systematic review and meta-analysis
Masri A, Altibi A, Erqou S, Zmaili M, Saleh A, Al-Adham R, Ayoub K, Barakat A, Jain S, Saba S, Adelstein E. P1025Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a systematic review and meta-analysis. European Heart Journal 2018, 39: ehy564.p1025. DOI: 10.1093/eurheartj/ehy564.p1025.Peer-Reviewed Original ResearchPrevention of sudden cardiac deathCardioverter-defibrillator therapySudden cardiac deathCardiac deathMeta-analysisSystematic review
2016
Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure
Echouffo-Tcheugui JB, Masoudi FA, Bao H, Spatz ES, Fonarow GC. Diabetes Mellitus and Outcomes of Cardiac Resynchronization With Implantable Cardioverter-Defibrillator Therapy in Older Patients With Heart Failure. Circulation Arrhythmia And Electrophysiology 2016, 9 PMID: 27489243, DOI: 10.1161/circep.116.004132.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyDevice-related complicationsDiabetes mellitusResynchronization therapyHeart failureHazard ratioOlder patientsHigh riskHeart failure-related readmissionsImplantable Cardioverter-Defibrillator RegistryImplantable cardioverter-defibrillator therapyNational Cardiovascular Data RegistryDiabetes mellitus statusCardioverter-defibrillator therapyCause readmissionMellitus statusDefibrillator implantationRenal failureProcedural complicationsCardiac resynchronizationDevice implantationQRS durationOdds ratioMellitusSimilar risk
2015
Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest
Chan PS, Krumholz HM, Spertus JA, Curtis LH, Li Y, Hammill BG, Nallamothu BK, investigators A. Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest. American Heart Journal 2015, 169: 870-878.e1. PMID: 26027626, PMCID: PMC4451609, DOI: 10.1016/j.ahj.2015.02.016.Peer-Reviewed Original ResearchConceptsInhospital cardiac arrestLong-term mortalityHospital cardiac arrestCardiac arrestICD treatmentLower long-term mortalityImplantable cardioverter-defibrillator therapyHigh illness acuityHigher unadjusted mortalityICD-treated patientsCardiac Arrest RegistryCardioverter-defibrillator therapyPulseless ventricular tachycardiaHigh-risk populationComparative effectiveness studiesLong-term survivalPropensity score analysisLower mortality rateArrest etiologyEligible survivorsICD trialsHospital deathICD therapyIndex hospitalizationUntreated patients
2014
Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
Masoudi FA, Mi X, Curtis LH, Peterson PN, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Qualls LG, Hernandez AF. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Annals Of Internal Medicine 2014, 160: 603-11. PMID: 24798523, DOI: 10.7326/m13-1879.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overCardiac Resynchronization TherapyComparative Effectiveness ResearchDefibrillators, ImplantableElectrocardiographyHeart FailureHumansInfectionsPatient ReadmissionPropensity ScoreRetrospective StudiesRisk FactorsStroke VolumeTreatment OutcomeVentricular Dysfunction, LeftConceptsReduced left ventricular ejection fractionLeft ventricular ejection fractionHeart failure readmissionVentricular ejection fractionCardiac resynchronization therapyICD therapyQRS durationLower riskCohort studyICD RegistryResynchronization therapyEjection fractionNational Cardiovascular Data Registry ICD RegistryImplantable cardioverter-defibrillator therapyLeft bundle branch blockPropensity-matched patientsRetrospective cohort studyCardioverter-defibrillator therapyDevice-related complicationsBundle branch blockDevice-related infectionsCardiovascular readmissionCause readmissionDefibrillator therapyICD implantation
2013
Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials
Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials. JAMA 2013, 309: 55-62. PMID: 23280225, PMCID: PMC3638257, DOI: 10.1001/jama.2012.157182.Peer-Reviewed Original ResearchConceptsPrimary prevention ICDsPrimary prevention clinical trialsTrial-eligible patientsSurvival of patientsPrevention clinical trialsClinical trialsICD RegistrySCD-HeFTClinical practiceRegistry patientsMADIT-IISimilar patientsNational Cardiovascular Data Registry ICD RegistryPrimary prevention implantable cardioverter defibrillatorsSurvival rateImplantable cardioverter-defibrillator therapyMADIT II criteriaMADIT II patientsSCD-HeFT criteriaCardioverter-defibrillator therapyClinical trial patientsLarge national registryRandomized clinical trialsProportional hazards modelImplantable cardioverter defibrillator
2010
Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD. Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. Circulation 2010, 122: 597-602. PMID: 20660803, DOI: 10.1161/circulationaha.110.940619.Peer-Reviewed Original ResearchConceptsSudden unexpected deathRecurrent MISudden deathArrhythmic deathAutopsy recordsUnexpected deathAcute Myocardial Infarction trialImplantable cardioverter-defibrillator therapyEarly post-myocardial infarction periodPost-myocardial infarction periodMyocardial Infarction trialCardioverter-defibrillator therapySudden death eventsIndex MILack of benefitSeries of casesCardiovascular causesNoncardiovascular causesVentricular dysfunctionAcute MICardiac ruptureHeart failureAutopsy evidenceClinical groundsAutopsy findings
2009
Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy
Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP, Masoudi FA. Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy. Circulation 2009, 119: 1078-1084. PMID: 19221223, DOI: 10.1161/circulationaha.108.793463.Peer-Reviewed Original ResearchConceptsHospital adverse eventsImplantable cardioverter-defibrillator therapyMajor adverse eventsAdverse eventsCardioverter-defibrillator therapyICD implantationHigh riskNational Cardiovascular Data Registry ICD RegistryNew York Heart Association functional statusFirst-time ICD implantationAdverse event ratesInvasive cardiac proceduresHeart failureICD RegistryNonischemic cardiomyopathyMultivariable analysisCardiac proceduresUnadjusted analysesFunctional statusHospital characteristicsBiventricular ICDsMultivariable modelEvent ratesPatientsWomen
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply